TimothyJByrneDO
Cardiology • Phoenix, AZAdult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology
Physician
Dr. Byrne is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2777 E Camelback Rd
Ste 200
Phoenix, AZ 85016Phone+1 602-952-0002Fax+1 602-224-9119
Summary
- Dr. Timothy Byrne is a cardiologist in Phoenix, AZ and is affiliated with multiple hospitals in the area, including Arizona Heart Hospital, Banner - University Medical Center Phoenix, Carondelet St. Joseph's Hospital, St. Joseph's Hospital and Medical Center, and Wickenburg Community Hospital. He received his medical degree from A.T. Still University Kirksville College of Osteopathic Medicine and has been in practice 28 years. He specializes in adult congenital heart disease, cardiac electrophysiology, and interventional cardiology and is experienced in interventional cardiology.
Education & Training
Allegheny Health Network Medical Education Consortium (AGH)Fellowship, Cardiovascular Disease, 1995 - 1996
University of Arizona College of Medicine-PhoenixFellowship, Cardiovascular Disease, 1992 - 1995
Cleveland Clinic FoundationResidency, Internal Medicine, 1989 - 1992
A. T. Still University Kirksville College of Osteopathic MedicineClass of 1989
Certifications & Licensure
AZ State License 1992 - 2025
OH State License 1990 - 2013- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
- Join now to see all
Clinical Trials
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2010 Dec 10
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). Start of enrollment: 2012 Apr 01
- Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2012 Aug 01
Publications & Presentations
PubMed
- 163 citationsEarly safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium.Matthew J. Price, Douglas N. Gibson, Steven J. Yakubov, Jason C. Schultz, Luigi Di Biase
Journal of the American College of Cardiology. 2014-08-12 - 23 citations1-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Results.Firas Zahr, Howard K Song, Scott Chadderdon, Hemal Gada, Mubashir Mumtaz
JACC. Cardiovascular Interventions. 2023-12-11 - 13 citationsFirst-in-Human Multicenter Experience of the Newest Generation Supra-Annular Self-Expanding Evolut FX TAVR System.Syed Zaid, Guilherme F Attizzani, Parasuram Krishnamoorthy, Sung-Han Yoon, Luis A Palma Dallan
JACC. Cardiovascular Interventions. 2023-07-10
Press Mentions
New Tricuspid Valve Study Launches at Abrazo Arizona Heart HospitalJuly 7th, 2021- 10 COVID-19 Vaccine Questions Answered by DoctorJanuary 21st, 2021
Here’s How Abrazo Arizona Heart Hospital Has Distinguished ItselfFebruary 5th, 2020- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
